Forte Biosciences, Inc. (FBRX) › Shareholders' EquityForte Biosciences, Inc. (FBRX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2014: -$70.44M2015: -$92.33M2016: -$124.42M2017: $71.08M2018: -$736.0K2019: -$4.77M2020: $58.98M2021: $41.55M2022: $38.82M2023: $35.31M2024: $52.48M2025: $60.99M$60.99M2014Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$60.99M+16.2%2024$52.48M+48.6%2023$35.31M-9.0%2022$38.82M-6.6%2021$41.55M-29.6%2020$58.98M+1336.7%2019-$4.77M-548.0%2018-$736.0K-101.0%2017$71.08M+157.1%2016-$124.42M-34.8%2015-$92.33M-31.1%2014-$70.44M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share